Study EV-103 cohort L: Perioperative treatment w/ enfortumab vedotin (EV) monotherapy in cisplatin (cis)ineligible patients (pts) w/ muscle invasive bladder cancer (MIBC) Meeting Abstract
| Authors: | Sridhar, S.; O'Donnell, P. H.; Flaig, T. W.; Rosenberg, J. E.; Hoimes, C. J.; Milowsky, M. I.; Srinivas, S.; George, S.; McKay, R. R.; Petrylak, D. P.; Coelho Barata, P. M.; Hwang, C.; Cruz-Correa, M.; Iafolla, M.; Mckean, M.; Dreicer, R.; Brancato, S.; Lukas, J. J.; Yu, Y.; Moon, H. |
| Abstract Title: | Study EV-103 cohort L: Perioperative treatment w/ enfortumab vedotin (EV) monotherapy in cisplatin (cis)ineligible patients (pts) w/ muscle invasive bladder cancer (MIBC) |
| Meeting Title: | ESMO Congress 2023 |
| Journal Title: | Annals of Oncology |
| Volume: | 34 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2023 Oct 20-24 |
| Meeting Location: | Madrid, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2023-10-01 |
| Start Page: | S1203 |
| Language: | English |
| ACCESSION: | WOS:001087480203360 |
| DOI: | 10.1016/j.annonc.2023.09.1014 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 2365MO -- Source: Wos |
